TY - JOUR
T1 - Successful revascularization improves long-term clinical outcome in patients with chronic coronary total occlusion
AU - Teramoto, Tomohiko
AU - Tsuchikane, Etsuo
AU - Yamamoto, Masanori
AU - Matsuo, Hitoshi
AU - Kawase, Yoshiaki
AU - Suzuki, Yoriyasu
AU - Kanou, Seiji
AU - Shimura, Tetsurou
AU - Sato, Hirotomo
AU - Habara, Maoto
AU - Nasu, Kenya
AU - Kimura, Masashi
AU - Kinoshita, Yoshihisa
AU - Terashima, Mitsuyasu
AU - Matsubara, Tetsuo
AU - Suzuki, Takahiko
N1 - Publisher Copyright:
© 2016 The Authors
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Background Following the development of breakthrough techniques for percutaneous coronary intervention (PCI) in the treatment of chronic total occlusions (CTO), the initial success rate of PCI in CTO lesions (CTO-PCI) has improved; however, there are few reports regarding the effects of successful CTO revascularization on long-term mortality in Japan. The aim of this study was to compare the long-term clinical outcomes of patients with successful versus failed CTO recanalization and to identify related factors. Methods and results From all PCI procedures performed in our hospital between 2006 and 2013, CTO-PCIs were extracted and classified into two groups: PCI success (n = 656 patients) and PCI failure (n = 82 patients). Patients with successful procedures only on a second attempt, CTO-PCI in small branches, or CTOs in more than one vessel were excluded. Survival was determined from a telephone interview or the consultation history in the outpatient clinic. Initial angiographic success was achieved in 88.9% of the patients. A Kaplan–Meier plot with log-rank analysis showed that cumulative all-cause death was significantly lower in the success group than in the failure group (p = 0.0003; average follow-up duration in success group vs. failure group was 1531.3 ± 33.5 vs. 1565.3 ± 97.5 days, p = 0.7). Moreover, the rate of evident cardiac death was significantly lower in the success group than in the failure group (3.5% [23/656] vs. 15.9% [13/82], p < 0.0001). Conclusions This study suggests that successful revascularization in patients with CTO improves their long-term clinical outcomes.
AB - Background Following the development of breakthrough techniques for percutaneous coronary intervention (PCI) in the treatment of chronic total occlusions (CTO), the initial success rate of PCI in CTO lesions (CTO-PCI) has improved; however, there are few reports regarding the effects of successful CTO revascularization on long-term mortality in Japan. The aim of this study was to compare the long-term clinical outcomes of patients with successful versus failed CTO recanalization and to identify related factors. Methods and results From all PCI procedures performed in our hospital between 2006 and 2013, CTO-PCIs were extracted and classified into two groups: PCI success (n = 656 patients) and PCI failure (n = 82 patients). Patients with successful procedures only on a second attempt, CTO-PCI in small branches, or CTOs in more than one vessel were excluded. Survival was determined from a telephone interview or the consultation history in the outpatient clinic. Initial angiographic success was achieved in 88.9% of the patients. A Kaplan–Meier plot with log-rank analysis showed that cumulative all-cause death was significantly lower in the success group than in the failure group (p = 0.0003; average follow-up duration in success group vs. failure group was 1531.3 ± 33.5 vs. 1565.3 ± 97.5 days, p = 0.7). Moreover, the rate of evident cardiac death was significantly lower in the success group than in the failure group (3.5% [23/656] vs. 15.9% [13/82], p < 0.0001). Conclusions This study suggests that successful revascularization in patients with CTO improves their long-term clinical outcomes.
KW - Chronic total coronary occlusion
KW - Coronary artery disease
KW - Drug-eluting stent
KW - Percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=85000788505&partnerID=8YFLogxK
U2 - 10.1016/j.ijcha.2016.11.001
DO - 10.1016/j.ijcha.2016.11.001
M3 - Article
AN - SCOPUS:85000788505
VL - 14
SP - 28
EP - 32
JO - IJC Heart and Vasculature
JF - IJC Heart and Vasculature
SN - 2352-9067
ER -